Philips Respironics, ResMed Inc, and biopharmaceutical company Cephalon Inc are supporting efforts to bring untreated sleep apnea to the forefront of discussion among primary care physicians. As the program enters its second year, Cephalon joins the device makers in responding to educational grant requests to fund a series of independent continuing medical education (CME) activities on this topic.

For the program year, educational activities will take place in 24 US cities. The first series of OSA CME activities will be conducted at Primary Care Education’s Best Practices in Primary Care, accredited by Primary Care Network. OSA education will also be conducted at Pri-Med’s Conference & Exhibitions with those programs accredited by pmiCME. The programs run from October 2010 through June 2011. This year’s goal is to educate 10,200 clinicians.

The activities have been designed with the objective of improving understanding in identifying, treating, and managing patients with OSA. They are available to primary care, family practice, and internal medicine physicians, nurse practitioners, and physician assistants.